Skip to main content


The development activities at HELM concentrate on prescription drugs for distribution through retail pharmacies and hospitals, predominantly in the following indication fields:

  • Infectious diseases 
  • Central nervous system 
  • Cardiovascular system 
  • Women's health
  • Cancer therapy

A specialized marketing team offers a broad range of services and HELM's international distribution organization ensures our presence in all major markets worldwide.

Highest quality standards are ensured by HELM's quality control laboratory and an established quality assurance system. All suppliers of HELM's business unit Pharma are carefully selected and regularly audited. As holder of a manufacturing authorization according to Directive 2001/83/EC HELM can offer EU batch analysis and batch release for customers.

A specialized team works on projects in the field of international development cooperation.

Recognizing the increasing importance of biotechnologically engineered pharmaceuticals, HELM began operating in this field in 2007 through a  joint venture established with the Hungarian multinational pharma company Gedeon Richter. Today, Richter-Helm BioLogics GmbH & Co. KG and Richter-Helm BioTec GmbH & Co. KG are engaged in biopharmaceutical development and manufacturing.

In 2010, a participation in Amarin Technologies S.A., Buenos Aires provided HELM's pharmaceutical division with direct access to various generic transdermal products.

Annette Eschler

Dr. Annette Eschler

Executive Director Pharma

a.eschler@helmag.com Business Card